NCT01855854 2019-07-05
Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH
Betta Pharmaceuticals Co., Ltd.
Phase 2 Completed
Clinical Trials
3 trialsNCT02375581 2016-03-22
Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
First People's Hospital of Hangzhou
Phase 2 Unknown
NCT02278458 2015-05-22
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 1 Unknown